In order to operate the site and better serve you, we collect your data. We also use this data and share with our vendors for the purposes of marketing, research, and monitoring.
Overview Fabhalta is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to treat adults with paroxysmal nocturnal hemoglobinuria (PNH). Fabhalta is also known by its drug name, iptacopan.… read more
Join